A Phase III Randomized Feasibility Study Comparing Stereotactic Body Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) For Patients With Spinal Metastases
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Clinical Trial Registration
Related Post
27 October, 2026
MASTERPLAN trial shows benefit from SBRT in pancreatic cancer
LATEST NEWS: 27 October 2026 Findings from the AGITG/TROG
21 October, 2026
Jess’s deeply personal reason for joining TROG’s Km’s for Cancer Research challenge
LATEST NEWS: 21 October 2026 For Jess Synge, taking